Published on 27.02.18 in Vol 4, No 1 (2018): Jan-Mar
Works citing "Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study"
According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.9282):
(note that this is only a small subset of citations)
- Abramova N, Hubbard J, Schertz J, Richter E. Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development. Drug Safety 2019;42(3):453CrossRef
- Small SS, Hohl CM, Balka E. Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systems. Healthcare Management Forum 2019;32(4):208CrossRef
- Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. Journal of Drug Assessment 2019;8(1):13CrossRef
- Peddie D, Small SS, Badke K, Bailey C, Balka E, Hohl CM. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset. JMIR Medical Informatics 2018;6(2):e10248CrossRef